A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents

Clinical trial NCT01143077 · COMPLETED

Trial details

NCT number: NCT01143077
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2010-06-01
Primary completion: 2011-05-01
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.